Hematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousHematopoietic Stem CellsGraft vs Host DiseaseTransplantation, AutologousStem Cell TransplantationTransplantation ConditioningBone MarrowBone Marrow CellsTissue DonorsHematologic NeoplasmsWhole-Body IrradiationTransplantation ChimeraPeripheral Blood Stem Cell TransplantationStem CellsGraft SurvivalLiver TransplantationLeukemiaHistocompatibility TestingBusulfanHistocompatibilityTreatment OutcomeHematopoiesisAnemia, AplasticRecurrenceCord Blood Stem Cell TransplantationRetrospective StudiesCombined Modality TherapyKidney TransplantationImmunosuppressive AgentsRemission InductionHematopoietic Stem Cell MobilizationTransplantation, IsogeneicCyclophosphamideGraft vs Leukemia EffectAntigens, CD34Leukemia, Myeloid, AcuteHepatic Veno-Occlusive DiseaseMyeloablative AgonistsTime FactorsMice, Inbred C57BLBone and BonesChimerismHLA AntigensCell DifferentiationHematologic DiseasesTransplantation ImmunologyMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaSevere Combined ImmunodeficiencySurvival AnalysisBone Marrow PurgingGraft RejectionMultiple MyelomaGraft vs Tumor EffectSurvival RateColony-Forming Units AssayLymphocyte TransfusionCell TransplantationLymphocyte DepletionDisease-Free SurvivalMesenchymal Stem Cell TransplantationFlow CytometryMelphalanAcute DiseaseT-LymphocytesImmunosuppressionCell LineageLymphoma, Non-HodgkinHeart TransplantationBone Marrow DiseasesLeukemia, MyeloidGranulocyte Colony-Stimulating FactorCytomegalovirus InfectionsSiblingsRadiation ChimeraLiving DonorsAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesVidarabineAntilymphocyte SerumUnrelated DonorsLung TransplantationOrgan TransplantationCells, CulturedSalvage TherapyFetal BloodCyclosporineStem Cell NicheCell SeparationCytarabineOpportunistic InfectionsEmbryonic Stem CellsPrognosisLeukocyte TransfusionTransplantationAdult Stem CellsImmunocompromised Host